 Research
 Open access
 Published:
Beyond just “flattening the curve”: Optimal control of epidemics with purely nonpharmaceutical interventions
Journal of Mathematics in Industry volume 10, Article number: 23 (2020)
Abstract
When effective medical treatment and vaccination are not available, nonpharmaceutical interventions such as social distancing, home quarantine and farreaching shutdown of public life are the only available strategies to prevent the spread of epidemics. Based on an extended SEIR (susceptibleexposedinfectiousrecovered) model and continuoustime optimal control theory, we compute the optimal nonpharmaceutical intervention strategy for the case that a vaccine is never found and complete containment (eradication of the epidemic) is impossible. In this case, the optimal control must meet competing requirements: First, the minimization of diseaserelated deaths, and, second, the establishment of a sufficient degree of natural immunity at the end of the measures, in order to exclude a second wave. Moreover, the socioeconomic costs of the intervention shall be kept at a minimum. The numerically computed optimal control strategy is a singleintervention scenario that goes beyond heuristically motivated interventions and simple “flattening of the curve”. Careful analysis of the computed control strategy reveals, however, that the obtained solution is in fact a tightrope walk close to the stability boundary of the system, where socioeconomic costs and the risk of a new outbreak must be constantly balanced against one another. The model system is calibrated to reproduce the initial exponential growth phase of the COVID19 pandemic in Germany.
1 Introduction
Preventing the spread of new diseases, to which there is no immunity in the population, is a huge problem, since there are often neither vaccines nor other effective medical treatments available in the early stages. In this case, nonpharmaceutical interventions (NPIs) such as intensive hand hygiene, home quarantine and measures of social distancing, e.g. closure of schools, universities and shops, prohibition of mass events up to curfew and shutdown of entire territories, are the only available measures. The NPIs are aimed at “flattening the curve”, i.e., a reduction of the transmission rate in order to break the exponential growth of the epidemic.
In the case of the currently spreading COVID19 pandemic caused by the new SARSCoV2 coronavirus [1, 2], the fundamental concern of the mitigation measures is not to exceed the available number of intensive care unit (ICU) beds, in particular for respiratory support or extracorporeal membrane oxygenation, in order to prevent actually avoidable deaths [3]. Since the outbreak of the epidemic, a large number of simulation studies have been conducted using mathematical models to assess the efficacy of different NPIs and to estimate the corresponding demands on the health care system [4–12]. Moreover, mathematical models are employed to deduce important epidemiological parameters [13–15] and to evaluate the effect of particular measures from empirical data [16, 17].
The vast majority of research papers on the control of COVID19 examines the impact of rather simple intervention schemes such as bangbang control or cascaded onoff (i.e., repeated lockdown and release) strategies [12, 18–20]. Instead, however, intervention strategies derived from continuoustime optimal control theory [21] following a variational principle are actually preferable. There is a large number of studies on the application of optimal control theory following Pontryagin’s maximum principle [22] in mathematical epidemiology, see Refs. [23–27] and references therein. The by far largest part of these works deals with optimal control of epidemics through vaccination and immunization [28–31], medical treatment [32, 33] and combinations thereof [34–39]. Significantly fewer papers are concerned with the optimal control of transmission dynamics and the mitigation of epidemics through social distancing measures. The paper by Behncke [25] studies the optimal control of transmission dynamics via optimally steered healthpromotion campaigns and seems to be one of the first works devoted to this problem. During the current COVID19 pandemic, the control of the disease by NPIs has moved into the focus of attention and a number of recent papers are devoted to this problem. DjidjouDemasse et al. [40] investigated the optimal control of the epidemic via social distancing and lockdown measures until a vaccine becomes available. They propose to delay the peak of the epidemic by increasingly strict interventions and finally to relax the measures in such a way that a significant burden on the health care system only occurs when the availability of a vaccine is already expected. A similar problem has been considered by Perkins and España [41], who studied the optimal implementation of NPIs under the assumption that an effective vaccine would become available in about one year after the outbreak of the epidemic. The paper by Kruse and Strack [42] is devoted to the analysis of the optimal timing of social distancing measures under the constraint that the overall (temporal) budget for NPIs is limited. Ketcheson [43] presented a detailed analysis for optimal transmission control in a SIR (susceptibleinfectedrecovered) epidemic model with the aim of achieving a stable equilibrium (“herd immunity”) within a fixed finite time interval while simultaneously avoiding hospital overflow. A similar problem (including a simple statedependent mortality rate) was studied by Alvarez et al. [44], who focussed on minimizing the lockdown costs and included further economic aspects such as the assumed value of statistical life. An extension of the optimal transmission control problem to an agestructured model has been presented by Bonnans and Gianatti [45], who proposed a different temporal course of the contact reduction for the high and low risk subpopulations. Köhler et al. [46] have applied model predictive control to social distancing measures with the objective of minimizing the fatalities over a fixed period of time of two years. Next to adaptive feedback strategies for iterative loosening of the social distancing policies after an initial lockdown, the authors also examined the possibility of eradicating the virus. All of these papers on optimal control deal with deterministic epidemiological models, in particular the basic SIR model [25, 42–44, 47] or various extended SEIRtype models [40, 41, 46]. We remark that this survey on optimal control of COVID19 is not exhaustive.
The objective of this paper is the investigation of the optimal control of epidemics in the (hopefully unlikely) case in which an effective vaccine is impossible or never found and the epidemic must be controlled with purely nonpharmaceutical measures. Furthermore, we exclude the possibility of complete containment (“eradication of the virus”). Then, optimal control must pursue competing objectives: On the one hand, the number of diseaserelated deaths shall be minimized by strictly avoiding an overload of the intensive care treatment capacities. On the other hand, however, sufficient natural immunity must be established in the population in the long run to prevent a second outbreak of the epidemic (“herd immunity”). Moreover, the socioeconomic costs of the intervention shall be kept at a minimum. We compute the optimal solution to this problem by applying Pontryagin’s Maximum Principle to an extended SEIRtype model tailored to specific aspects of COVID19. Our main result is the optimal time course of the mean contact reduction (and the corresponding timedependent effective reproduction number) that serves as a guideline on how to optimally enter and finally exit the lockdown. The corresponding NPI policy is a singleintervention scenario that can be divided into three distinct phases: (1) a strict initial lockdown, (2) a long lasting period (“critical period”) during which the number of active cases is kept approximately constant and (3) a moderate tightening of the measures towards the end of the intervention. We present a detailed analysis of the numerically computed result and develop an analytical understanding of its distinct features. Moreover, we show that our numerically computed optimal control obeys two fundamental stability criteria, which impose an upper limit on the transmission rate and its rate of change on the way out of the initial lockdown. The precise structure of the optimal control (i.e., three phases of the intervention) obtained in this paper differs from the results described in similar works [42–44]. After the initial submission of this paper, the preprint by Charpentier et al. [48] appeared, who studied a similar optimization problem on the basis of an extended SIRtype model with parameters adjusted to the COVID19 pandemic in France. Their independently obtained results are comparable to those presented in this paper, which demonstrates the robustness of the obtained optimal intervention strategy with respect to model and parameter variations.
The mathematical model for the progression of the epidemic and the estimation of the demand for intensive care resources is described in Sect. 2. The optimal control problem is derived in Sect. 3 and the results are described in Sect. 4. We close with a critical discussion of our findings in Sect. 5. The model has been calibrated to reproduce the exponential growth phase of the COVID19 pandemic in Germany. Details on the parameter adjustment are described in the Appendix.
2 Modeling of disease spreading and demand for intensive care units
Mathematical modeling of the spread of epidemics is an indispensable tool to project the outcome of an epidemic, estimate important epidemiological parameters and to make predictions for different intervention scenarios. Compartment models [49–51], where the population is divided into different macroscopic subpopulations, such as susceptible, infectious, recovered etc., are a simple but effective tool to model the progression of epidemics. In contrast to complex (but more realistic) stochastic agentbased models [52, 53], deterministic meanfield models are limited to the description of the average infection dynamics in macroscopic (sub)populations, but allow for fast parameter scans and a straightforward application of continuoustime optimal control theory [21].
2.1 Model equations
In this paper, an extended SEIR model, similar to that proposed by Neher et al. [54, 55], is used to model the spread of an epidemic and to estimate the number of patients in a critical state that require intensive care. Similar models are described in Refs. [14, 46, 56]. For the sake of simplicity, vital dynamics (except for diseaserelated deaths), seasonality effects [57], dispersion of transmission [58] and any effects caused by population heterogeneity (different age and risk groups) are neglected. The total population is divided into distinct compartments: susceptible S, exposed E, infectious I, hospitalized H (severely ill), critical C, recovered R (i.e., immune) and deceased D. The model equations read
The group of initially healthy and not yet infected (susceptible, S) is vulnerable to infection through contact with infectious (I), who may transmit the disease to the susceptible population. The infection probability is determined by the transmission rate β, and the share of the susceptible and infectious population on the total (living) population \(N=N(t)\), which is given as
The newly infected (exposed, E) become infectious themselves only after a latency period \(\gamma _{l}^{1}\) (which must not be confused with the incubation time). The infectious either recover or turn severely ill after an average period \(\gamma _{i}^{1}\). Severely ill (H) can either deteriorate into a critical state (C) or recover after a period \(\gamma _{h}^{1}\). The recovered population (R) is assumed to be immune against new infections. Patients in a critical state either stabilize to the severely ill state or die from the disease on a time scale \(\gamma _{c}^{1}\). The diseaserelated deaths reduce the size of the population
such that, assuming initially \(D (0 )=0\), it holds \(N (t )=N (0 )D (t )\). Moreover, m is the share of infectious that are asymptomatic or have at most mild symptoms, c is the fraction of severely ill that become critical and f is the fraction of critically ill that are going to die from the disease. Finally, the timedependent function \(u (t )\) describes a modification of the transmission rate (mean contact reduction) due to NPIs. Here, \(u=1\) means no intervention, and \(u=0\) corresponds to the extreme case of total isolation of the whole population. The model system is illustrated in Fig. 1(a). A rescaled version of the dynamical system (1a)–(1g), where the subpopulations are considered in terms of their relative share of the initial population \(N (0 )\), is given in Eq. (23a)–(23g) in the Appendix D.
2.2 Statedependent fatality rate
The diseaserelated mortality grows tremendously as soon as the number of critically ill exceeds the capacity limit \(C_{0}\) of the health care system (number of available ICUs). This is modeled by a statedependent average fatality rate
As long as every critical patient can be served with an ICU (\(C\leq C_{0}\)), the fatality rate is a constant \(f=f_{0}\). As soon as the ICU resources are exceeded, an increasing fraction of the critical patients dies with a higher rate \(f_{1}>f_{0}\), which on average results in the statedependent fatality rate (4a). Here, \(f_{1}=2f_{0}\) is assumed. In the following, the regularization
with \(0<\epsilon \ll 1\), of Eq. (4a) is used, in order to avoid problems due to the nondifferentiability at \(C=C_{0}\). The function \(f (C/C_{0} )\) is plotted in Fig. 1(b).
2.3 Basic and effective reproduction number
The basic reproduction number [59]
can be thought of as the expected number of cases (without intervention, \(u=1\)) that is directly generated by one case in a population where all individuals are susceptible to infection. The effective reproduction number
depends on time and includes the impact of intervention measures.
2.4 Numerical results for the uncontrolled epidemic (COVID19 in Germany)
Figure 2 shows the progression of an uncontrolled epidemic starting from an initially small fraction of exposed population. The initial conditions are listed in Appendix D. The parameters are adjusted (see Appendix C) to reproduce the initial exponential growth phase of the COVID19 disease in Germany (late February – mid March 2020) and are summarized in Table 1. The numerical solution was obtained by a 4th order Runge–Kutta method. Without intervention, the peak number of simultaneously active cases is about 23 million and the peak number of patients in a critical state exceeds the number of ICUs by a factor of about \(C_{\text{max}}/C_{0}\approx 16.7\), see inset of Fig. 2(a). The simulated value \(C_{\text{max}}\approx 5.0\times 10^{5}\) is in very good agreement with the projection by Khailaie et al. [14]. Due to the increased fatality in the period with ICU overflow, see Eq. (4a)–(4b), the epidemic terminates with a very high number of deaths \(D (T )\approx 1.0\times 10^{6}\), which is in line with previous studies [11].
3 Optimal control
In the scenario outlined in Sect. 1, where an effective vaccine is never found, the optimal transmission control due to NPIs is required (i) to avoid ICU overflow (more patients in a critical state than available ICUs) but at the same time (ii) exclude a second wave of the epidemic after the end of the measures. The optimal solution is computed by minimizing the index functional
where
is the terminal cost function. The first term in Eq. (7b) describes the number of diseaserelated deaths \(D (T )\) at the end of the epidemic, which should be minimized. As the increment of the diseaserelated deaths depends on the statedependent fatality rate, see Eq. (1g), this condition implies that the ICU capacities must not be exceeded. The second term in Eq. (7b) controls the size of the of susceptible population \(S (T )\) at the end of the epidemic. In order to approach a stable, diseasefree stationary state (“herd immunity”), the share of susceptibles on the total population must be less than \(\mathcal{R}_{0}^{1}\) at the end of the intervention, see Appendix A. The term in Eq. (7b) enforces a final state slightly below the stability boundary (just in the stable regime), where \(0<\varepsilon \ll 1\) is a small parameter. We use \(\varepsilon =10^{2}\) in the numerical simulations throughout this paper. The function
is convex on the whole domain \(x\in [0,\infty )\). It appears also in the last term of Eq. (7a) as an intermediate cost function, which provides an abstract measure for the total socioeconomic costs caused by the intervention. The term is minimal and zero if no intervention is applied \(\mathcal{C} (1 )=\mathcal{C}' (1 )=0\), see Fig. 3. The advantage of using (8) over the commonly used quadratic cost functions is that “unphysical” negative values of u are a priori excluded. The control parameter \(\mathcal{P}\) balances between the competing objectives of minimal diseaserelated deaths (first term), while attaining at the same time a minimum number of cases to enforce \(S (T )\) slightly below the stability boundary (second term). Ramping up \(\mathcal{P}\) puts an increasing emphasis on minimizing the diseaserelated deaths. The time interval \([0,T]\) of the simulation is chosen sufficiently large, such that the results are practically independent from the chosen final time T, see Table 1.
From the augmented index functional [21]
where \(\mathbf{x}= (S,E,I,H,C,R,D )\) is the state vector, \(\dot{\mathbf{x}}=\mathbf{F} (\mathbf{x},u )\) is the dynamical system (1a)–(1g) and \(\boldsymbol{\lambda } (t )\) is a vector of timedependent Lagrange multipliers (also denoted as costate variables) \(\boldsymbol{\lambda }= (\lambda _{S},\lambda _{E},\lambda _{I}, \lambda _{H},\lambda _{C},\lambda _{R},\lambda _{D} )\), one obtains the Hamiltonian function
Following Pontryagin’s maximum principle [21, 22], the optimality condition reads
Finally, the costate equations and the final time conditions are obtained as
Together with the initial conditions \(\mathbf{x} (0 )\), the system (1a)–(1g), (11)–(12) represents a nonlinear twopoint boundary value problem. The full set of equations is given in Appendix D. Numerical solutions are obtained by using Matlab’s builtin routine bvp4c [60] in combination with an analytic Jacobian matrix and a stepsize adaptive homotopy method, where the control parameter \(\mathcal{P}\) is gradually ramped up while always using the result of the previous step as initialization. The procedure is initiated from the numerical solution of the initial value problem (1a)–(1g) without interventions, see Fig. 2.
4 Results
4.1 Structure of the optimal intervention strategy
With optimal control of the transmission rate (in the sense of Sect. 3) via accordingly steered NPIs, the epidemic develops dramatically different from the uncontrolled case. The whole intervention is shown in Fig. 4 and can be structured into three phases:

1.
The intervention begins with a strict initial “lockdown” that is built up over a period of about 25 days (starting around day 25), see Fig. 4(a), (b). The effective reproduction number (6) must be held below one \(\mathcal{R}_{\text{eff}}<1\) for about 13 days, see Fig. 4(b) and Fig. 5(b). This strict initial intervention breaks the early exponential growth and damps the peak number of infected such that an overshoot of the critically ill population beyond \(C_{0}\) is just barely avoided, see Fig. 4(a) and Fig. 5(c).

2.
The initial lockdown is followed by a long period (about 300 days in the case of \(C_{0}=30\text{,}000\)), which is denoted as the “critical period” in the following, during which the number of simultaneously active cases is kept approximately constant. This corresponds to an effective reproduction number \(\mathcal{R}_{\text{eff}}\approx 1\), see Fig. 4(b). During this phase, the intensive care system is constantly stressed by slightly less than \(C_{0}\) patients in a critical state. This situation must of course be avoided in reality by all means, in particular, since stochastic fluctuations of the case number are not included in the deterministic model (1a)–(1g) at all. During this period, the NPIs are relaxed on a gradually increasing rate, but initially (when the disease is not yet widespread in the population) only very slowly, see Fig. 4(b). The duration of the critical period scales with \(C_{0}^{1}\). Further details are discussed in Sect. 4.3 below.

3.
After the critical period, i.e., when the number of active cases starts to decay, a final moderate tightening of the measures is required. This is reflected by a notable dip in the transmission control function and a reduction of the effective reproduction number below one, see Fig. 4(b). This final intervention reflects the requirement to meet the herd immunity threshold towards the end of the intervention. An unnecessarily wide overshooting into the stable regime would result in additional infections and deaths, see Sect. 4.4. Finally, the measures are lifted on a gradually decreasing rate while the system slowly approaches the herd immunity threshold.
Figure 4(c) shows the trajectories of the controlled and the uncontrolled epidemic in different state space projections. By controlling the transmission of infection, the enormous excursion of the trajectory is prevented and the optimal path to a stable diseasefree stationary state is taken. Note that the uncontrolled epidemic terminates far in the stable regime (\(S(T)/N (T )\ll \mathcal{R}_{0}^{1}\)), whereas in the optimally controlled case the final state is just slightly below the stability threshold .
We point out that the optimal transmission control described above differs from the results obtained for similar optimization problems considered in Refs. [43, 44, 47], which do not exhibit the distinct structural features of the intervention (initial lockdown, critical period, final phase intervention) presented here. A comparable result was described in Ref. [48], where the intervention was divided into four different phases which essentially coincide with our findings. Merely the lockdown was further subdivided into a “quick activation of a strong lockdown” and a “light lockdown release.”
4.2 Dependence on the maximum number of simultaneously critical cases
The statedependent mortality rate (4a)–(4b) effectively imposes a stateconstraint that strictly enforces \(C< C_{0}\) for \(\mathcal{P}\to \infty \), i.e., a maximum number of simultaneously infected in a critical condition. In principle, this allows to investigate the optimal control of other (less extreme) scenarios, where the maximum number of simultaneously critically infected should be held far below the number of available ICUs (i.e., the meaning of \(C_{0}\) will be reinterpreted). In this case, the increased mortality rate \(f_{1}\) is an artificial parameter that penalizes the excess of the critically infected population over a freely chosen threshold of \(C_{0}\). By ramping up the control parameter \(\mathcal{P}\), an optimal solution with \(C (t )< C_{0}\) for all \(t\in [0,\infty )\) is found, that is independent of \(f_{1}\).
Figure 5 shows the optimal control for different values of \(C_{0}\). The time course of the optimally controlled transmission rate is qualitatively the same for all considered values of \(C_{0}\), see Fig. 5(a), (b). Most notably, the time scale of the entire intervention scenario is governed by the duration of the critical period, during which the number of critical patients is held at , see Fig. 5(c). We characterize this time scale by the full width half maximum (FWHM) time \(T_{\text{FWHM}}=t_{2}t_{1}\), where \(t_{1}\) and \(t_{2}>t_{1}\) are the two points in time at which the number of critically infected equals half the allowed maximum value: \(C (t_{1} )=C (t_{2} )=C_{0}/2\). As shown in Fig. 5(d), the FWHM time scales inversely with the peak number of simultaneously infected in a critical state: \(T_{\text{FWHM}}\sim C_{0}^{1}\). The minimization of the diseaserelated deaths is controlled by the parameter \(\mathcal{P}\) in the terminal cost function (7b). Figure 5(e) displays the progression of the optimization routine into the targeted optimal state (i.e., without excess of \(C_{0}\)) while \(\mathcal{P}\) is ramped up. At a certain value of \(\mathcal{P}\), which depends on \(C_{0}\), the routine reaches a plateau where both the number of diseaserelated deaths as well as the total costs of the intervention measures \(\int _{0}^{T}\mathrm{d}t \,\mathcal{C} (u (t ) )\) become constant. The corresponding values of \(\mathcal{P}\), which correspond to the scenario that fully avoids excess of critically ill over \(C_{0}\), are located on that plateau and are marked by square symbols in Fig. 5(e). The optimized transmission function minimizes the number of diseaserelated deaths to a \(C_{0}\)independent value \(D_{\text{min}} (T )\) for \(\mathcal{P}\to \infty \), but at total cost that scales with \(C_{0}^{1}\). An analytical estimate of the minimum attainable number of deaths is given in Eq. (18).
Within the present model, further reduction of diseaserelated deaths below \(D_{\text{min}} (T )\) can only be achieved by pharmaceutical interventions, in particular by vaccination. The result of the \(C_{0}\)independent number of deaths at the end of the epidemic is an artifact of the simplified modeling framework, in which a homogeneous population with an averaged set of parameters is considered. Since the mortality rate typically strongly depends on age and health condition, it might be advisable to extend the model and divide the compartments into several age or risk groups as in Refs. [11, 45, 54, 61]. The soextended model features a matrixvalued transmission rate, which describes the infections caused by contacts within and between different groups, that could be further optimized by intra and intergroupspecific measures. This is, however, beyond the scope of this paper.
4.3 Analysis of the critical period
The numerical results shown in Fig. 4(a), (b) indicate that during the critical period the populations S, R, and D change approximately linear, while the active cases (E, I, H, C) are practically constant. To gain further insights, we consider the ansatz (for \(t>t^{*}\))
where \(t^{\ast }\) is a reference time that depends on the initial conditions, \(\gamma _{S}\), \(\gamma _{R}\), \(\gamma _{D}\) are initially unknown rates and the infected subpopulations \((E,I,H,C )\approx (E^{\ast },I^{\ast },H^{\ast },C_{0} )\) are constant. From substituting the ansatz into the model equations (1a)–(1g), one obtains by a straightforward calculation analytical expressions for the rates
and the constants
The rate of new infections per day \(\gamma _{S}\) during the critical period depends only on the parameters of the disease and the maximum capacity \(C_{0}\). Note that it holds \(\gamma _{S}=\gamma _{R}+\gamma _{D}\), i.e., the number of active cases remains constant since susceptibles become infected at the same rate on which active cases either recover or die. The number of active cases in this dynamical equilibrium is a multiple of \(C_{0}\):
With the parameters listed in Table 1, we find \(N_{\text{act}}^{\ast }\approx 28.3 C_{0}\), i.e., one out of about thirty infections turns critical.
Let us now come to the major results of this section. The ansatz stated above yields an instantaneous relationship between the current value of the transmission control function and the share of the susceptibles on the total population \(S(t)/N(t)\), which is
for a certain range of t in \(t^{\ast }< t< T_{\text{crit}}\) with \(T_{\text{crit}}\) defined below. Here, we approximated \(N (t )\approx N (0 )\) (since \(\gamma _{D}\ll \gamma _{S}\)). Note that Eq. (13) implies \(\mathcal{R}_{\text{eff}}\approx 1\) during the critical period. This approximate relation is an interesting result, as it hints that the obtained optimal control steers the system’s trajectory close to the stability boundary. Comparison with the stability criterion for the diseasefree stationary state \(\mathcal{R}_{0}<\bar{N}/\bar{S}\), see Eq. (19), suggests that during the critical period one must make sure that \(\mathcal{R}_{\text{eff}} (t )<1\), i.e.,
This allows to have a stable control of the number of active cases, while the intervention measures can be gradually relaxed. Stable means that sufficiently small fluctuations of the number of infected are damped and do not lead to a new exponential outbreak of the epidemic. Indeed, substituting \(u (t )= (1+\varepsilon )N (t )/( \mathcal{R}_{0}S (t ))\) into the model equations (1a)–(1g) yields a linear, autonomous dynamical system (up to the statedependent mortality rate (4a)–(4b)), which is easily seen to evolve close to a stable dynamical equilibrium for \(\varepsilon <0\) and \(\vert \varepsilon \vert \ll 1\), see Appendix B. The optimal transmission control function is shown in Fig. 6 along with the analytical approximation (13), the stability criterion (14) and the corresponding effective reproduction number for the critical period.
We formulate the stability criterion (14) once again in a different way. Since it holds \(S (t )\approx N (0 )N_{\text{cases}} (t )\), where \(N_{\text{cases}} (t )\) is the cumulative number of cases that includes next to the active cases also the recovered and deceased population \(N_{\text{cases}} (t )=N_{\text{act}} (t )+R (t )+D (t )\), the stability criterion (14) can be written as
Hence, since the optimal control depends solely on the cumulative number of cases, it is crucial to have an accurate estimate of \(N_{\text{cases}}\) at any time during the critical period. Next, we derive an upper limit for the admissible rate of change of \(u(t)\). By differentiating Eq. (14), using Eq. (1a) and approximating \(N (t )\approx N (0 )\) as well as \(I(t)\approx I^{\ast }\) (see above), we obtain
Using the approximation (13), the rate on which the measures can be relaxed is limited by the square of the current value of the control function. It holds
The numerically computed optimal control obeys the criteria (15)–(16), see Fig. 6, and is therefore (weakly) stable against small perturbations. The merely weak stability reflects the demand for minimal socioeconomic costs, see Sect. 3. The two rules (15)–(16) for the optimal and stable steering of the transmission control function are widely independent of the details of the current model system. Equivalent results for a stable dynamical equilibrium with a constant number of infected cases are easily obtained for the much simpler SIR model.
The characteristic duration \(T_{\text{crit}}\) of the critical period is estimated from Eq. (13) and the condition \(u (t^{\ast }+T_{\text{crit}} )\approx 1\). One obtains
which is in excellent agreement with the numerically obtained values for the FWHM time plotted in Fig. 5(d). Finally, we estimate of the total number of diseaserelated deaths from \(D (T )\approx D (t^{*}+T_{\text{crit}} ) \approx \gamma _{D}T_{\text{crit}}\) as
which is independent of \(C_{0}\), cf. Sect. 4.2 and Fig. 5(e).
4.4 Final phase of the intervention
Finally, we briefly discuss the moderate tightening of the measures in the last (third) phase of the intervention. To this end, we compare the optimal intervention scenario with a nearly optimal control, which lacks the last intervention phase as shown in Fig. 7. In the case of nearly optimal control, the mean contact reduction after the initial lockdown continuously follows the course of the stability boundary (14), which leads to an excess of infections beyond the required herd immunity threshold, see Fig. 7(a). The final state therefore is considerably further in the stable region than required. This implies that more infections than necessary are passed through, which results in exceeding the minimum number of deaths (not shown), cf. Eq. (18). In order to prevent this, the measures must be slightly tightened towards the end of the intervention such that the number of active cases is diminished and thus an unnecessary decrease of the susceptible population below the herd immunity threshold is avoided.
5 Summary and conclusions
Nonpharmaceutical measures to control the spread of infectious diseases and to prevent a potential collapse of the health care system must be precisely coordinated in terms of timing and intensity. Based on wellcalibrated mathematical models, the optimal intervention strategy for specific scenarios and objectives can be computed using continuoustime optimal control theory.
In this paper, an extended SEIR model was calibrated to reproduce the data of the initial exponential growth phase of the COVID19 pandemic in Germany. Optimal control theory has been applied for the scenario in which an effective vaccine is impossible or will never be found and the epidemic must be controlled with purely nonpharmaceutical measures. We have computed the optimal control of the transmission rate that satisfies competing objectives: First, the minimization of the diseaserelated deaths by strictly avoiding an overflow of intensive care resources and, second, the suppression of a second outbreak by establishing sufficient natural immunity at the end of the measures. Moreover, the total costs of the intervention shall be kept at a necessary minimum for socioeconomic reasons.
The optimal control obtained in this paper is a singleintervention scenario that exhibits several notable features, which allow to structure the whole intervention into three distinct phases: (i) strict initial lockdown, (ii) critical period and (iii) moderate tightening of measures in the final phase. The obtained control differs from the results described in related works [43, 44, 47], but is comparable to the NPI strategy presented in Ref. [48]. We have shown that our optimized timeresolved NPI policy is robust under parameter variation and developed a qualitative understanding of its distinct phases.
The comparison of the computed optimal transmission control function with the stability criteria (15)–(16) reveals, however, that the obtained solution is in fact a tightrope walk close to the stability boundary of the system, where socioeconomic costs and the risk of a new outbreak must be constantly balanced against one another. Furthermore, our analysis clearly shows that the goal of achieving herd immunity via natural infections is either extremely expensive (in terms of socioeconomic costs due to measures maintained over a long period of time) or extremely dangerous (due to the constantly high load on intensive care resources just below the stability limit). Note that the values of \(C_{0}\) considered in the computations are relatively high throughout. In any case, in view of the long duration and the enormous number of infections that this route entails, as well as the uncertain role of sequelae and the uncertain prospects for appropriate vaccines, it is strongly advisable to consider other strategies, in particular the attempt to reduce the number of cases to a level that is manageable for case tracking [62] or to eradicate the epidemic completely [63].
Abbreviations
 COVID19:

coronavirus disease 2019
 FWHM:

full width half maximum
 ICU:

intensive care unit
 NPI:

nonpharmaceutical intervention
 S(E)IR:

susceptible(exposed)infectiousrecovered
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382(8):727–33. https://doi.org/10.1056/NEJMoa2001017.
Wu F, Zhao S, Yu B et al.. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–9. https://doi.org/10.1038/s4158602020083.
Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, Shrestha BR, Arabi YM, Ng J, Gomersall CD, Nishimura M, Koh Y, Du B. Intensive care management of coronavirus disease 2019 (COVID19): challenges and recommendations. Lancet Resp Med. 2020. https://doi.org/10.1016/s22132600(20)301612.
Ferguson NM, Laydon D, NedjatiGilani G et al. Impact of nonpharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College Lond (16032020) (2020). https://doi.org/10.25561/77482.
Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, Whittaker C, Zhu H, Berah T, Eaton JW, Monod M, Imperial College COVID19 Response Team, Ghani AC, Donnelly CA, Riley SM, Vollmer MAC, Ferguson NM, Okell LC, Bhatt S. Estimating the effects of nonpharmaceutical interventions on COVID19 in Europe. Nature. 2020. https://doi.org/10.1038/s4158602024057.
Chang SL, Harding N, Zachreson C, Cliff OM, Prokopenko M. Modelling transmission and control of the COVID19 pandemic in Australia. 2020. arXiv:2003.10218.
Ng KY, Gui MM. COVID19: development of a robust mathematical model and simulation package with consideration for ageing population and time delay for control action and resusceptibility. Phys D, Nonlinear Phenom. 2020;411:132599. https://doi.org/10.1016/j.physd.2020.132599.
Bouchnita A, Jebrane A. A hybrid multiscale model of COVID19 transmission dynamics to assess the potential of nonpharmaceutical interventions. Chaos Solitons Fractals. 2020;138:109941. https://doi.org/10.1016/j.chaos.2020.109941.
Jia J, Ding J, Liu S, Liao G, Li J, Duan B, Wang G, Zhang R. Modeling the control of COVID19: impact of policy interventions and meteorological factors. Electron J Differ Equ. 2020;23:1.
Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, Eggo RM, Sun F, Jit M, Munday JD, Davies N, Gimma A, van Zandvoort K, Gibbs H, Hellewell J, Jarvis CI, Clifford S, Quilty BJ, Bosse NI, Abbott S, Klepac P, Flasche S. Early dynamics of transmission and control of COVID19: a mathematical modelling study. Lancet Infect Dis. 2020;20(5):553–8. https://doi.org/10.1016/S14733099(20)301444.
Barbarossa MV, Fuhrmann J, Heidecke J, Vinod Varma H, Castelletti N, Meinke JH, Krieg S, Lippert T. A first study on the impact of current and future control measures on the spread of COVID19 in Germany. medRxiv 2020. https://doi.org/10.1101/2020.04.08.20056630.
Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARSCoV2 through the postpandemic period. Science. 2020;368(6493):860–8. https://doi.org/10.1126/science.abb5793.
Sesterhenn JL. Adjointbased data assimilation of an epidemiology model for the Covid19 pandemic in 2020. 2020. arXiv:2003.13071.
Khailaie S, Mitra T, Bandyopadhyay A, Schips M, Mascheroni P, Vanella P, Lange B, Binder S, MeyerHermann M. Estimate of the development of the epidemic reproduction number \(R_{t}\) from coronavirus SARSCoV2 case data and implications for political measures based on prognostics. medRxiv 2020. https://doi.org/10.1101/2020.04.04.20053637.
Engbert R, Rabe MM, Kliegl R, Reich S. Sequential data assimilation of the stochastic SEIR epidemic model for regional COVID19 dynamics. medRxiv 2020. https://doi.org/10.1101/2020.04.13.20063768.
Dehning J, Zierenberg J, Spitzner FP, Wibral M, Neto JP, Wilczek M, Priesemann V. Inferring change points in the spread of COVID19 reveals the effectiveness of interventions. Science. 2020. https://doi.org/10.1126/science.abb9789.
Brauner JM, Mindermann S, Sharma M, Stephenson AB, Gavenčiak T, Johnston D, Salvatier J, Leech G, Besiroglu T, Altman G, Ge H, Mikulik V, Hartwick M, Teh YW, Chindelevitch L, Gal Y, Kulveit J. The effectiveness and perceived burden of nonpharmaceutical interventions against COVID19 transmission: a modelling study with 41 countries. medRxiv 2020. https://doi.org/10.1101/2020.05.28.20116129.
Tsay C, Lejarza F, Stadtherr MA, Baldea M. Modeling, state estimation, and optimal control for the US COVID19 outbreak. Sci Rep. 2020;10:10711. https://doi.org/10.1038/s41598020674598.
Tarrataca L, Dias CM, Haddad DB, Arruda EF. Flattening the curves: onoff lockdown strategies for COVID19 with an application to Brazil. 2020. arXiv:2004.06916.
Bin M, Cheung P, Crisostomi E, Ferraro P, Lhachemi H, MurraySmith R, Myant C, Parisini T, Shorten R, Stein S, Stone L. On fast multishot COVID19 interventions for post lockdown mitigation. 2020. arXiv:2003.09930.
Lewis FL, Vrabie D, Syrmos VL. Optimal control. New York: Wiley; 2012. https://doi.org/10.1002/9781118122631.
Pontryagin LS, Boltyanskii VG, Gamkrelidze RV, Mishchenko EF. The mathematical theory of optimal processes. New York: Wiley; 1962.
Wickwire K. Mathematical models for the control of pests and infectious diseases: a survey. Theor Popul Biol. 1977;11(2):182–238. https://doi.org/10.1016/00405809(77)900259.
Sharomi O, Malik T. Optimal control in epidemiology. Ann Oper Res. 2015;251(1–2):55–71. https://doi.org/10.1007/s1047901518344.
Behncke H. Optimal control of deterministic epidemics. Optim Control Appl Methods. 2000;21(6):269–85. https://doi.org/10.1002/oca.678.
Nowzari C, Preciado VM, Pappas GJ. Analysis and control of epidemics: a survey of spreading processes on complex networks. IEEE Control Syst Mag. 2016;36(1):26–46. https://doi.org/10.1109/MCS.2015.2495000.
Lenhart S, Workman JT. Optimal control applied to biological models. Boca Raton: Chapman & Hall/CRC Press; 2007. https://doi.org/10.1201/9781420011418.
Morton R, Wickwire KH. On the optimal control of a deterministic epidemic. Adv Appl Probab 1974;6(4):622–35. https://doi.org/10.1017/s0001867800028482.
Abakuks A. Optimal immunisation policies for epidemics. Adv Appl Probab. 1974;6(3):494–511. https://doi.org/10.2307/1426230.
Zaman G, Han Kang Y, Jung IH. Stability analysis and optimal vaccination of an SIR epidemic model. Biosystems. 2008;93(3):240–9. https://doi.org/10.1016/j.biosystems.2008.05.004.
Kar T, Batabyal A. Stability analysis and optimal control of an SIR epidemic model with vaccination. Biosystems. 2011;104(2):127–35. https://doi.org/10.1016/j.biosystems.2011.02.001.
Zaman G, Kang YH, Jung IH. Optimal treatment of an SIR epidemic model with time delay. Biosystems. 2009;98:43–50. https://doi.org/10.1016/j.biosystems.2009.05.006.
Liddo AD. Optimal control and treatment of infectious diseases. The case of huge treatment costs. Mathematics. 2016;4(2):21. https://doi.org/10.3390/math4020021.
Gaff H, Schaefer E. Optimal control applied to vaccination and treatment strategies for various epidemiological models. Math Biosci Eng. 2009;6:469–92. https://doi.org/10.3934/mbe.2009.6.469.
Hansen E, Day T. Optimal control of epidemics with limited resources. J Math Biol. 2011;62(3):423–51. https://doi.org/10.1007/s0028501003410.
Iacoviello D, Stasio N. Optimal control for sirc epidemic outbreak. Comput Methods Programs Biomed. 2013;110(3):333–42. https://doi.org/10.1016/j.cmpb.2013.01.006.
Bolzoni L, Bonacini E, Soresina C, Groppi M. Timeoptimal control strategies in SIR epidemic models. Math Biosci. 2017;292:86–96. https://doi.org/10.1016/j.mbs.2017.07.011.
Barro M, Guiro A, Ouedraogo D. Optimal control of a SIR epidemic model with general incidence function and a time delays. CUBO. 2018;20(2):53–66. https://doi.org/10.4067/s071906462018000200053.
Bolzoni L, Bonacini E, Della Marca R, Groppi M. Optimal control of epidemic size and duration with limited resources. Math Biosci. 2019;315:108232. https://doi.org/10.1016/j.mbs.2019.108232.
DjidjouDemasse R, Michalakis Y, Choisy M, Sofonea MT, Alizon S. Optimal COVID19 epidemic control until vaccine deployment. medRxiv 2020. https://doi.org/10.1101/2020.04.02.20049189.
Perkins TA, España G. Optimal control of the COVID19 pandemic with nonpharmaceutical interventions. medRxiv 2020. https://doi.org/10.1101/2020.04.22.20076018.
Kruse T, Strack P. Optimal control of an epidemic through social distancing. SSRN Electron J 2020;3581295. https://doi.org/10.2139/ssrn.3581295.
Ketcheson DI. Optimal control of an sir epidemic through finitetime nonpharmaceutical intervention. 2020. arXiv:2004.08848.
Alvarez FE, Argente D, Lippi F. A simple planning problem for COVID19 lockdown. Cambridge, MA. 2020. Tech. rep, NBER Working Paper No. 26981.
Bonnans JF, Gianatti J. Optimal control techniques based on infection age for the study of the COVID19 epidemic. 2020. HAL02558980v2.
Köhler J, Schwenkel L, Koch A, Berberich J, Pauli P, Allgöwer F. Robust and optimal predictive control of the COVID19 outbreak. 2020. arXiv:2005.03580.
Miclo L, Spiro D, Weibull J. Optimal epidemic suppression under an ICU constraint. 2020. arXiv:2005.01327.
Charpentier A, Elie R, Laurière M, Tran VC. COVID19 pandemic control: balancing detection policy and lockdown intervention under ICU sustainability. 2020. arXiv:2005.06526.
Kermack WO, McKendrick AG, Walker GT. A contribution to the mathematical theory of epidemics. Proc R Soc Lond ACONTA. 1927;115(772):700–21. https://doi.org/10.1098/rspa.1927.0118.
Hethcote HW. The mathematics of infectious diseases. SIAM Rev. 2000;42(4):599–653. https://doi.org/10.1137/s0036144500371907.
Brauer F. Compartmental models in epidemiology. In: Mathematical epidemiology. Berlin: Springer; 2008. p. 19–79. https://doi.org/10.1007/9783540789116_2.
Epstein JM. Modelling to contain pandemics. Nature. 2009;460:687. https://doi.org/10.1038/460687a.
Rahmandad H, Sterman J. Heterogeneity and network structure in the dynamics of diffusion: comparing agentbased and differential equation models. Manag Sci. 2008;54(5):998–1014. https://doi.org/10.1287/mnsc.1070.0787.
Neher R, Aksamentov I, Noll N, Albert J, Dyrdak R. COVID19 scenarios. Online (2020). https://github.com/neherlab/covid19_scenarios. Accessed on April 16, 2020
Noll NB, Aksamentov I, Druelle V, Badenhorst A, Ronzani B, Jefferies G, Albert J, Neher R. COVID19 scenarios: an interactive tool to explore the spread and associated morbidity and mortality of SARSCoV2. medRxiv 2020. https://doi.org/10.1101/2020.05.05.20091363.
Wilson N, Telfar Barnard L, Kvalsig A, Verrall A, Baker MG, Schwehm M. Modelling the potential health impact of the COVID19 pandemic on a hypothetical European country. medRxiv 2020. https://doi.org/10.1101/2020.03.20.20039776.
Neher RA, Dyrdak R, Druelle V, Hodcroft EB, Albert J. Potential impact of seasonal forcing on a SARSCoV2 pandemic. Swiss Med Wkly. 2020;150:w20224. https://doi.org/10.4414/smw.2020.20224.
LloydSmith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438:355–9. https://doi.org/10.1038/nature04153.
Diekmann O, Heesterbeek JAP, Metz JAJ. On the definition and the computation of the basic reproduction ratio \(R_{0}\) in models for infectious diseases in heterogeneous populations. J Math Biol. 1990;28:365–82. https://doi.org/10.1007/bf00178324.
Shampine LF, Gladwell I, Shampine L, Thompson S. Solving ODEs with Matlab. Cambridge: Cambridge University Press; 2003. https://doi.org/10.1017/cbo9780511615542.
Richard Q, Alizon S, Choisy M, Sofonea MT, DjidjouDemasse R. Agestructured nonpharmaceutical interventions for optimal control of COVID19 epidemic. medRxiv 2020. https://doi.org/10.1101/2020.06.23.20138099.
MeyerHermann M, Pigeot I, Priesemann V, Schöbel A. Adaptive Strategien zur Eindämmung der COVID19Epidemie. 2020. Tech. rep, Accessed on July 13, 2020. https://www.mpg.de/14760567/28042020_Stellungnahme_Teil_02.pdf.
Wiestler OD, Marquardt W, Heinz D, MeyerHermann M. Stellungnahme der HelmholtzInitiative “Systemische Epidemiologische Analyse der COVID19Epidemie”. (April 13, 2020) (2020). https://www.helmholtz.de/fileadmin/user_upload/01_forschung/HelmholtzCOVID19Papier_02.pdf. Accessed on April 17, 2020.
Robert KochInstitute: Archiv der Situationsberichte des Robert KochInstituts zu COVID19. Online (2020). https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Archiv.html. Accessed on April 15, 2020
NPGEO Corona: RKI COVID19. Online (2020). https://npgeocoronanpgeode.hub.arcgis.com/datasets/dd4580c810204019a7b8eb3e0b329dd6_0/. Accessed on April 16, 2020
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (COVID19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82. https://doi.org/10.7326/M200504.
KochInstitute R. (COVID19). Online (2020). SARSCoV2 Steckbrief zur CoronavirusKrankheit2019. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html. Accessed on April 14, 2020.
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, CuomoDannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunubá Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, NedjatiGilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. Estimates of the severity of coronavirus disease 2019: a modelbased analysis. Lancet Infect Dis. 2020;20(6):669–77. https://doi.org/10.1016/s14733099(20)302437.
Robert KochInstitute: Täglicher Lagebericht des RKI zur CoronavirusKrankheit2019 (COVID19): April 8, 2020. Online (2020). https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/20200408de.pdf. Accessed on April 14, 2020
German Interdisciplinary Society for Intensive Care Medicine (DIVI): DIVI Intensivregister. https://www.divi.de/register/intensivregister
Robert KochInstitute: Täglicher Lagebericht des RKI zur CoronavirusKrankheit2019 (COVID19): March 27, 2020. Online (2020). https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/20200327de.pdf. Accessed on April 14, 2020
Acknowledgements
Not applicable.
Availability of data and materials
Data were taken from online resources as cited and described in detail in Appendix C. Matlab source codes can be made available upon request.
Funding
Open access funding provided by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
MK initiated the research, implemented the numerical routines, performed the numerical and analytical calculations and prepared the figures. TK initiated the analysis that lead to the qualitative understanding of the optimal control and its stability during the “critical period”. Both authors contributed to the interpretation of the results and wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Appendices
Appendix A: Stability analysis of the diseasefree stationary state
Without intervention, i.e. \(u=1\), the system (1a)–(1g) has a family of diseasefree stationary states \(\bar{\mathbf{x}}= (\bar{S},0,0,0,0,\bar{R},\bar{D} )\). The stability of a stationary state with respect to small perturbations \(\bar{\mathbf{x}}\to \bar{\mathbf{x}}+\delta \mathbf{x} (t )\) is determined by the sign of the real parts of the eigenvalues η of the linearized system’s coefficient matrix
with \(\bar{N}=\bar{S}+\bar{R}\). From the characteristic polynomial
one obtains the eigenvalues
and the threefold degenerate eigenvalue \(\eta ^{ (0 )}=0\). Since \(c (1f_{0} )<1\), it holds \(\eta _{\pm }^{ (2 )}<0\). The leading eigenvalue is \(\eta _{+}^{ (1 )}\), which is negative for
see Fig. 8. Hence, the diseasefree stationary state is unstable if the susceptible population size exceeds a critical threshold value that is given by the inverse basic reproduction number (5). For \(\bar{S}/\bar{N}<\mathcal{R}_{0}^{1}\) an epidemic outbreak is suppressed by a sufficiently high degree of herd immunity.
Appendix B: Dynamical equilibrium and stability during the critical period
For the stability analysis of the dynamical equilibrium during the critical period it is sufficient to consider the \((S,E,I )\)block of the system (1a)–(1g), which drives the remaining equations. At first,
is a nonlinear and nonautonomous dynamical system. Substituting the control function
yields a linear and autonomous system
For \(\varepsilon =0\), it is easily seen that \(\dot{E}+\dot{I}=0\), such that there exists a dynamical equilibrium with a constant number of actively infected: \(E^{*}+I^{*}=\text{const}\)., where \(E^{*}= (1+\gamma _{i}/\gamma _{l} )I^{*}\). The corresponding susceptible population is linearly decreasing on a rate \(\gamma _{S}=\gamma _{i}I^{*}\). The stability of the dynamical equilibrium \((E^{*},I^{*} )\) is determined by the roots of the characteristic polynomial
that are obtained as
Clearly, for \(\varepsilon >0\), the dynamical equilibrium becomes unstable due to \(\varLambda _{+}>0\). The stability boundary is given by \(\varepsilon =0\), on which the dynamical equilibrium exists. The optimal control obtained in the main text drives the system slightly below the stability boundary (\(\varepsilon <0\), \(\vert \varepsilon \vert \ll 1\)), see Fig. 6(a). In this case it holds \(\varLambda _{\pm }<0\), such that the system is weakly stable against small perturbations, because the number of active cases is constantly decreasing.
Appendix C: Parameter adjustment
The parameters are adjusted such that the model reproduces the data of the early exponential growth phase of the COVID19 pandemic in Germany. It is of course questionable to calibrate an epidemic model to a single country, but in a scenario with extensive border closures this seems to be justified. In the exponential growth phase of the epidemic, all subpopulations grow exponentially with the same rate, see Fig. 2(b). This observation can be exploited to derive a series of algebraic equations (which hold approximately in the initial phase of the epidemic) that relate all state variables to each other. On the basis of empirical data (reported number of cases and deaths etc.), several missing model parameters can be directly determined from the algebraic relations. The number of reported cases and deaths used in this study is based on the figures provided by the Robert KochInstitute [64, 65].
One starts with the ansatz
where Γ is the initial exponential growth rate that is estimated from reported data (see Fig. 2(b)) as \(\varGamma \approx 0.26 \text{d}^{1}\) (doubling time of infections within \(\varGamma ^{1}\log { (2 )}\approx 2.67 \text{d}\)). Substituting Eq. (20) in Eqs. (1b)–(1c) yields
and the relation between the growth rate and \(\mathcal{R}_{0}\):
Note that Eq. (21) is equivalent to the equation for the leading eigenvalue \(\eta _{+}^{ (1 )}\) if the whole population is susceptible, i.e. \(\varGamma =\eta _{+}^{ (1 )}\vert _{\bar{S}=N(0)}\) (see Appendix A). Hence, Eq. (21) implies that the exponential growth rate Γ changes sign at \(\mathcal{R}_{0}=1\), i.e., the epidemic recedes for \(\mathcal{R}_{0}<1\). The mean incubation period was reported to be 5.1d, but there are indications that the latency time may be shorter [66]. Assuming the onset of infectiousness 2.5d before the onset of symptoms, this implies an average latency period of \(\gamma _{l}^{1}=2.6 \text{d}\), i.e., the latency period is assumed to equal roughly half of the incubation period. The reported values of the basic reproduction number \(\mathcal{R}_{0}\) are heavily scattered. According to the Robert Koch Institute, serious estimates range between 2.4 and 3.3 [67]. In the following \(\mathcal{R}_{0}=2.7\) shall be used, which is situated approximately in the middle of the interval in question. From Eq. (21), the corresponding average infectious period is obtained as \(\gamma _{i}^{1}\approx 2.35 \text{d}\).
The overall infection fatality rate of COVID19 was estimated as 0.66% [68], such that \((1m )cf_{0}=0.0066\). On April 8, the Robert Koch Institute reported that a fraction of \(f_{0}=0.31\) patients in a critical state died (without ICU overflow) [69]. Finally, the fraction of infected with at most mild symptoms is estimated as \(m=0.92\), such that \(c=0.0213/ (1m )\approx 0.266\).
Substituting the exponential ansatz (20) in Eqs. (1d)–(1g), yields
with \(K=1+ (\gamma _{h}+\gamma _{c} )/\varGamma +\gamma _{c} \gamma _{h} (1 (1f_{0} )c )/\varGamma ^{2}\). The analytically obtained ratio between all subpopulation and deaths (which are believed to be the most reliably reported data) are plotted along with the corresponding numerically exact result for the initial uncontrolled epidemic in Fig. 9(b). The analytical results imply the relation
Unfortunately, there is only little data available on the demand for ICUs in the early phase of the epidemic. In midMarch 2020, i.e. near the end of the initial exponential growth phase, the German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) initiated a register that reports on the availability of ICUs in Germany [70]. On March 27, 687 out of 1160 hospitals with ICUs contributed to the register and reported a total number of 939 COVID19 patients in a critical state receiving intensive care [71]. At the same day, 253 diseaserelated deaths were reported. From the estimated ratio \(C/D\approx 6.3\) (the actual number of critical patients was estimated based on the ratio of contributing and noncontributing hospitals as \(C\approx 1586\)), the average period after which patients in a critical state either recover or die, is estimated from Eq. (22) as \(\gamma _{c}^{1}\approx 7.5 \text{d}\).
Finally, assuming that only \(r=2/3\) of all cases have been discovered initially and an assumed average time delay between infection and report of cases of \(\Delta t_{r}=5 \text{d}\), the number of actual cases is estimated from the number of reported cases as \(N_{\text{cases}}^{\text{est}} (t )=r^{1}N_{\text{cases}}^{ \text{rep}} (t+\Delta t_{r} )=r^{1}\mathrm{e}^{\varGamma \Delta t_{r}}N_{\text{cases}}^{\text{rep}} (t )\approx 5.5 N_{ \text{cases}}^{\text{rep}} (t )\). This yields a good agreement between the simulated number of cases (\(N_{\text{cases}}=E+I+H+C+R+D\)) and \(N_{\text{cases}}^{\text{est}}\) before measures came into force, see Fig. 2(a) and Fig. 9. The average time between infection and death \(\Delta t_{d}\) can be estimated from the ratio \(N_{\text{cases}}^{\text{est}} (t )/D (t ) \approx 2370\) (see Fig. 8(b)) and \(N_{\text{cases}}^{\text{est}} (t\Delta t_{d} )=N_{ \text{cases}}^{\text{est}} (t )\mathrm{e}^{\varGamma \Delta t_{d}}=D (t )\) as \(\Delta t_{d}\approx 29.9 \text{d}\).
Appendix D: Twopoint boundary value problem
Rescaling the populations \(\mathbf{x}= (S,E,I,H,C,R,D )\) subject to the dynamical system (1a)–(1g) by the initial population size \(N(0)\) and using \(N (t )=N (0 )D (t )\), see Eq. (3), we obtain the equations of motion for the rescaled subpopulations \(\tilde{\boldsymbol{x}} (t )=\mathbf{x} (t )/N (0 )\) as
where \(\tilde{C}_{0}=C_{0}/N(0)\). The costate equations of the optimal control problem considered in Sect. 3 for the rescaled Lagrange multipliers \(\tilde{\boldsymbol{\lambda }} (t )=N (0 ) \boldsymbol{\lambda } (t )\) read
with
The initial conditions are taken as
and the final time conditions (12) read
The choice of the initial time conditions guarantees \(u (0 )=1\) (no intervention) at the beginning of the scenario.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kantner, M., Koprucki, T. Beyond just “flattening the curve”: Optimal control of epidemics with purely nonpharmaceutical interventions. J.Math.Industry 10, 23 (2020). https://doi.org/10.1186/s13362020000913
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13362020000913